ArticleFrontiers in endocrinology2026
A multimodal ultrasound-based model combining tumor radiomics and axillary lymph node morphologic classification for predicting axillary nodal burden in breast cancer.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate a multimodal ultrasound-based model integrating tumor radiomics and axillary lymph node (ALN) morphologic classification for preoperative prediction of axillary nodal metastasis burden in breast cancer. Methods: This retrospective study included 583 patients with pathologically confirmed breast cancer, randomly divided into training and testing cohorts (7:3). Radiomic features were extracted from primary tumor ultrasound images, and ALN classification and clinicopathological variables were collected. A hierarchical modeling strategy was applied: first-level models predicted ALN metastasis (N Results: At the first level, the radiomics model achieved an AUC of 0.79, while the combined model incorporating ALN classification improved performance to 0.90. At the second level, the radiomics model yielded an AUC of 0.74, which increased to 0.78 after integration. Ki-67 was identified as an independent predictor. Subgroup analysis showed that the combined model performed consistently well in predicting ALN metastasis across Ki-67 subgroups, whereas its performance in distinguishing nodal burden was superior in the low Ki-67 subgroup (AUC 0.82 vs. 0.68). Conclusion: The proposed multimodal model enables accurate, noninvasive prediction of ALN metastasis and axillary nodal tumor burden. Integrating tumor radiomics with lymph node morphology may support individualized risk stratification and treatment planning and optimize axillary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.